Skip to menu Skip to content Skip to footer

2018

Journal Article

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

van Ingen, Jakko, Aksamit, Timothy, Andrejak, Claire, Bottger, Erik C., Cambau, Emmanuelle, Daley, Charles L., Griffith, David E., Guglielmetti, Lorenzo, Holland, Steven M., Huitt, Gwen A., Koh, Won-Jung, Lange, Christoph, Leitman, Philip, Marras, Theodore K., Morimoto, Kozo, Olivier, Kenneth N., Santin, Miguel, Stout, Jason E., Thomson, Rachel, Tortoli, Enrico, Wallace, Richard J., Winthrop, Kevin L. and Wagner, Dirk (2018). Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. European Respiratory Journal, 51 (3) 1800170, 1800170. doi: 10.1183/13993003.00170-2018

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

2018

Journal Article

Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis

Choo, Jocelyn M., Abell, Guy C. J., Thomson, Rachel, Morgan, Lucy, Waterer, Grant, Gordon, David L., Taylor, Steven L., Leong, Lex E. X., Wesselingh, Steve L., Burr, Lucy D. and Rogers, Geraint B. (2018). Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis. mSphere, 3 (2) e00103-18, e00103-18. doi: 10.1128/mSphere.00103-18

Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis

2018

Journal Article

Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease

Baird, Timothy M. and Thomson, Rachel (2018). Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease. ERS Monograph, 2018, 204-221. doi: 10.1183/2312508X.10014818

Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease

2018

Conference Publication

Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC)

Winthrop, K. L., Eagle, G., Thomson, R. M., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O'Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L. C., Codecasa, L. R., Hill, A. T., Ruoss, S. J., Yim, J. J., Ringshausen, F. C., Field, S. K., Nezamis, J. and Griffith, D. E. (2018). Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC). International Conference of the American-Thoracic-Society, San Diego Ca, May 18-23, 2018. NEW YORK: AMER THORACIC SOC.

Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC)

2018

Conference Publication

Prevalence of nontuberculous mycobacteria (NTM) in potable water

Stockwell, R., Leong, L., Wood, M., Sherrard, L., Thomson, R., Rogers, G. and Bell, S. (2018). Prevalence of nontuberculous mycobacteria (NTM) in potable water. ANZSRS/TSANZ Annual Scientific Meeting, Adelaide, Australia, 23-27 March 2018. Richmond, VIC, Australia: Wiley-Blackwell.

Prevalence of nontuberculous mycobacteria (NTM) in potable water

2018

Conference Publication

Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients

Griffith, D. E., Eagle, G., Thomson, R. M., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O'Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L. C., Castellotti, P. F., Hill, A. T., Ruoss, S. J., Yim, J. J., Ringshausen, F. C., Field, S. K., Nezamis, J. and Winthrop, K. L. (2018). Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients. International Conference of the American-Thoracic-Society, San Diego Ca, May 18-23, 2018. NEW YORK: AMER THORACIC SOC.

Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients

2017

Journal Article

Mycobacterium shimoidei, a rare pulmonary pathogen, Queensland, Australia

Baird, Timothy M., Carter, Robyn, Eather, Geoffrey and Thomson, Rachel (2017). Mycobacterium shimoidei, a rare pulmonary pathogen, Queensland, Australia. Emerging Infectious Diseases, 23 (11), 1919-1922. doi: 10.3201/eid2311.170999

Mycobacterium shimoidei, a rare pulmonary pathogen, Queensland, Australia

2017

Book Chapter

Mycobacteria other than TB

Thomson, Rachel (2017). Mycobacteria other than TB. Management of tuberculosis: a guide for clinicians. (pp. 160-170) edited by Justin Denholm, Alan Street and Emma McBride. Canberra, ACT, Australia: Australasian Tuberculosis Program.

Mycobacteria other than TB

2017

Journal Article

Physical comorbidities of post-traumatic stress disorder in Australian Vietnam War veterans

McLeay, Sarah C., Harvey, Wendy M., Romaniuk, Madeline N. M., Crawford, Darrell H. G., Colquhoun, David M., Young, Ross McD., Dwyer, Miriam, Gibson, John M., O'Sullivan, Robyn A., Cooksley, Graham, Strakosch, Christopher R., Thomson, Rachel M., Voisey, Joanne and Lawford, Bruce R. (2017). Physical comorbidities of post-traumatic stress disorder in Australian Vietnam War veterans. Medical Journal of Australia, 206 (6), 251-257. doi: 10.5694/mja16.00935

Physical comorbidities of post-traumatic stress disorder in Australian Vietnam War veterans

2017

Journal Article

Notification of nontuberculous mycobacteria: an Australian perspective

Thomson, Rachel, Donnan, Ellen and Konstantinos, Anastasios (2017). Notification of nontuberculous mycobacteria: an Australian perspective. Annals of the American Thoracic Society, 14 (3), 318-323. doi: 10.1513/AnnalsATS.201612-994OI

Notification of nontuberculous mycobacteria: an Australian perspective

2017

Journal Article

A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease

Halstrom, Samuel, Cherry, Catherine L., Black, Michael, Thomson, Rachel, Goullee, Hayley, Baltic, Svetlana, Allcock, Richard, Temple, Suzanna E. L. and Price, Patricia (2017). A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease. Immunogenetics, 69 (5), 1-7. doi: 10.1007/s00251-017-0972-z

A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease

2017

Journal Article

Susceptibility to non-tuberculous mycobacterial disease is influenced by rs1518111 in IL10

Halstrom, Samuel, Thomson, Rachel, Goullee, Hayley, Baltic, Svetlana, Allcock, Richard, Temple, Suzanna E. L. and Price, Patricia (2017). Susceptibility to non-tuberculous mycobacterial disease is influenced by rs1518111 in IL10. Human Immunology, 78 (4), 391-393. doi: 10.1016/j.humimm.2017.02.001

Susceptibility to non-tuberculous mycobacterial disease is influenced by rs1518111 in IL10

2017

Conference Publication

The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New Zealand

Visser, Simone, Allan, Heather, Burr, Lucy, Chang, Anne, Holmes-Liew, Chien-Li, Hunter, Cameron, Jackson, Dan, King, Paul, Maguire, Graeme, Middleton, Peter, Smith, Daniel, Thomson, Rachel, Waterer, Grant, Wong, Conroy and Morgan, Lucy (2017). The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New Zealand. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Canberra, Australia, 24–28 March 2017. Richmond, VIC Australia: Wiley.

The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New Zealand

2017

Conference Publication

The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New Zealand

Visser, S., Allan, H., Burr, L., Chang, A., Holmes-Liew, C. -L., Hunter, C., Jackson, D., King, P., Maguire, G., Middleton, P., Smith, D., Thomson, R., Waterer, G. W., Wong, C. and Morgan, L. (2017). The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New Zealand. International Conference of the American-Thoracic-Society (ATS), Washington Dc, May 19-24, 2017. NEW YORK: AMER THORACIC SOC.

The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New Zealand

2016

Journal Article

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

Bryant, Josephine M., Grogono, Dorothy M., Rodriguez-Rincon, Daniela, Everall, Isobel, Brown, Karen P., Moreno, Pablo, Verma, Deepshikha, Hill, Emily, Drijkoningen, Judith, Gilligan, Peter, Esther, Charles R., Noone, Peadar G., Giddings, Olivia, Bell, Scott C., Thomson, Rachel, Wainwright, Claire E., Coulter, Chris, Pandey, Sushil, Wood, Michelle E., Stockwell, Rebecca E., Ramsay, Kay A., Sherrard, Laura J., Kidd, Timothy J., Jabbour, Nassib, Johnson, Graham R., Knibbs, Luke D., Morawska, Lidia, Sly, Peter D., Jones, Andrew ... Floto, R. Andres (2016). Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science, 354 (6313), 751-757. doi: 10.1126/science.aaf8156

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

2016

Journal Article

Culture-independent detection of nontuberculous mycobacteria in clinical respiratory samples

Scoleri, Gianny P., Choo, Jocelyn M., Leong, Lex E. X., Goddard, Thomas R., Shephard, Lisa, Burr, Lucy D., Bastian, Ivan, Thomson, Rachel M. and Rogers, Geraint B. (2016). Culture-independent detection of nontuberculous mycobacteria in clinical respiratory samples. Journal of Clinical Microbiology, 54 (9), 2395-2398. doi: 10.1128/JCM.01410-16

Culture-independent detection of nontuberculous mycobacteria in clinical respiratory samples

2016

Conference Publication

Immunopathogenesis of non-tuberculous mycobacterial infection in cystic fibrosis patients

Lutzky, , Ratnatunga, C., Thomson, R., Smith, D., Reid, D., Bell, S. and Miles, J. (2016). Immunopathogenesis of non-tuberculous mycobacterial infection in cystic fibrosis patients. International Congress of Immunology (ICI), Melbourne Australia, Aug 21-26, 2016. HOBOKEN: WILEY-BLACKWELL.

Immunopathogenesis of non-tuberculous mycobacterial infection in cystic fibrosis patients

2016

Conference Publication

Multivariate immunoprofiling of individuals prone to non-tuberculous mycobacterial infection reveals T cell exhaustion and dysfunction

Ratnatunga, C. N., Lutzky, V. P., Halstrom, S., Price, P., Smith, D. J., Reid, D. W., Bell, S. C., Thomson, R. M. and Miles, J. J. (2016). Multivariate immunoprofiling of individuals prone to non-tuberculous mycobacterial infection reveals T cell exhaustion and dysfunction. International Congress of Immunology (ICI), Melbourne, VIC, Australia, 21 - 26 August 2016. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA. doi: 10.1002/eji.201670200

Multivariate immunoprofiling of individuals prone to non-tuberculous mycobacterial infection reveals T cell exhaustion and dysfunction

2016

Journal Article

Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease

Ellender, Claire M., Law, Dayna B., Thomson, Rachel M. and Eather, Geoffrey W. (2016). Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease. Respirology, 21 (2), 357-362. doi: 10.1111/resp.12676

Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease

2016

Journal Article

Is pulmonary non-tuberculous mycobacterial disease linked with a high burden of latent cytomegalovirus?

Amran, Fathiah S., Kim, Kyungchul, Lim, Andrew, Thomson, Rachel, Lee, Silvia, Waterer, Grant and Price, Patricia (2016). Is pulmonary non-tuberculous mycobacterial disease linked with a high burden of latent cytomegalovirus?. Journal of Clinical Immunology, 36 (2), 113-116. doi: 10.1007/s10875-016-0233-1

Is pulmonary non-tuberculous mycobacterial disease linked with a high burden of latent cytomegalovirus?